Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer
Open Access
- 8 May 2006
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 119 (3), 599-607
- https://doi.org/10.1002/ijc.21902
Abstract
Molecular profiling is a powerful approach to identify potential clinical markers for diagnosis and prognosis as well as providing a better understanding of the biology of epithelial ovarian cancer. On the basis of the analysis of HuFL expression data, we have previously identified genes that distinguish low malignant potential and invasive serous epithelial ovarian tumors. In this study, we used immunohistochemistry to monitor a subset of differently expressed candidates (Ahr, Paep, Madh3, Ran, Met, Mek1, Ccne1, Ccd20, Cks1 and Cas). A tissue array composed of 244 serous tumors of different grades (0–3) and stages (I–IV) was used in this analysis. All markers assayed presented differential protein expression between serous tumors of low and high grade. Significant differences in Ccne1 and Ran expression were observed in a comparison of low malignant potential and grade 1 tumor samples (p < 0.01). In addition, irrespective of the grade, Ccne1, Ran, Cdc20 and Cks1 showed significant differences of expression in association with the clinical stage of disease. While high level of Ccne1 have previously been associated with poor outcomes, here we found that high level of either Ran or Cdc20 appear to be more tightly associated with a poor prognosis (p < 0.001, 0.03, respectively). The application of these biomarkers in both the initial diagnosis and prognostic attributes of patients with epithelial ovarian tumors should prove to be useful in patient management.Keywords
This publication has 57 references indexed in Scilit:
- β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: A study in 253 patientsEuropean Journal Of Cancer, 2005
- Plasma Bikunin As a Favorable Prognostic Factor in Ovarian CancerJournal of Clinical Oncology, 2005
- Mek1 Alters Epidermal Growth and DifferentiationCancer Research, 2004
- Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian CancerClinical Cancer Research, 2004
- Carcinoma of the ovaryInternational Journal of Gynecology & Obstetrics, 2003
- Pathology and classification of ovarian tumorsCancer, 2003
- Expression and Prognostic Value of the Cell-cycle Regulatory Proteins, Rb, p16MTS1, p21WAF1, p27KIP1, Cyclin E, and Cyclin D2, in Ovarian CancerInternational Journal of Gynecological Pathology, 2003
- CAS(Cellular Apoptosis Susceptibility) Gene Expression in Ovarian CarcinomaAmerican Journal of Clinical Pathology, 2002
- Localizing the EGF receptorNature, 2002
- EGF receptors as transcription factors: ridiculous or sublime?Nature, 2001